Literature DB >> 29373803

Knockdown of Nrf2 inhibits angiogenesis by downregulating VEGF expression through PI3K/Akt signaling pathway in cerebral microvascular endothelial cells under hypoxic conditions.

Yujing Huang1,1, Ying Mao1,1, Huiying Li1,1, Guangxun Shen1,1, Guangxian Nan1,1.   

Abstract

Ischemic stroke is a major cerebrovascular disease resulting from a transient or permanent local reduction of cerebral blood flow. Angiogenesis plays an important role in cerebral microvascular repair after ischemic stroke. This study aimed at investigating the effect of NF-E2-related factor 2 (Nrf2) on the angiogenesis of mouse cerebral microvascular endothelial bEnd.3 cells in a hypoxic environment. We found that Nrf2 expression was temporarily increased in hypoxia-induced bEnd.3 cells. Knockdown of Nrf2 inhibited the proliferation, migration, as well as tube formation in hypoxia-induced bEnd.3 cells. Meanwhile, vascular endothelial growth factor and PI3K/Akt signaling pathways were identified to be regulated by Nrf2 in hypoxia-induced bEnd.3 cells. It was found that silencing of Nrf2 downregulated the expression levels of NAD(P)H:quinine oxidoreductase-1, vascular endothelial growth factor, p-Akt, and heme oxygenase-1 in hypoxia-induced bEnd.3 cells. Data suggested that hypoxia induced the transient increase of Nrf2, which plays a key role in the angiogenesis of cerebral microangiogenesis, and that Nrf2 regulates the proliferation, migration, as well as tube formation likely through PI3K/Akt signaling pathway in hypoxia-induced bEnd.3 cells. Our study provides proof of concept for the modulation of Nrf2, so as to tilt the balance toward angiogenesis, representing a therapeutic strategy for hypoxia or ischemia disorders such as stroke.

Entities:  

Keywords:  NF-E2-related factor 2; Nrf2; angiogenesis; angiogenèse; cellules endothéliales; endothelial cells; facteur de croissance vasculaire endothélial; hypoxia; hypoxie; vascular endothelial growth factor

Mesh:

Substances:

Year:  2018        PMID: 29373803     DOI: 10.1139/bcb-2017-0291

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  10 in total

1.  To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K/Akt Signaling Pathway.

Authors:  Jia-Rong Gao; Xiu-Juan Qin; Zhao-Hui Fang; Li-Ping Han; Ming-Fei Guo; Nan-Nan Jiang
Journal:  J Diabetes Res       Date:  2019-04-17       Impact factor: 4.011

2.  A Network Pharmacology Approach to Investigate the Active Compounds and Mechanisms of Musk for Ischemic Stroke.

Authors:  Changlin Zhang; Yingdi Liao; Lingling Liu; Yifan Sun; Shaoqin Lin; Jiaying Lan; Hui Mao; Haoxuan Chen; Yuanqi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-03       Impact factor: 2.629

3.  VEGF signalling enhances lesion burden in KRIT1 deficient mice.

Authors:  Peter V DiStefano; Angela J Glading
Journal:  J Cell Mol Med       Date:  2019-11-20       Impact factor: 5.310

4.  Use of dual-flow bioreactor to develop a simplified model of nervous-cardiovascular systems crosstalk: A preliminary assessment.

Authors:  Nicoletta Marchesi; Annalisa Barbieri; Foroogh Fahmideh; Stefano Govoni; Alice Ghidoni; Gianfranco Parati; Emilio Vanoli; Alessia Pascale; Laura Calvillo
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

5.  Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD.

Authors:  Jie Zhang; Jie Tan; Mengke Wang; Yifen Wang; Mengzhen Dong; Xuefeng Ma; Baokai Sun; Shousheng Liu; Zhenzhen Zhao; Lizhen Chen; Kai Liu; Yongning Xin; Likun Zhuang
Journal:  Sci Adv       Date:  2021-11-03       Impact factor: 14.136

Review 6.  The molecular biology and therapeutic potential of Nrf2 in leukemia.

Authors:  Atefeh Khodakarami; Sara Adibfar; Vahid Karpisheh; Shiva Abolhasani; Pooya Jalali; Hamed Mohammadi; Jamshid Gholizadeh Navashenaq; Mohammad Hojjat-Farsangi; Farhad Jadidi-Niaragh
Journal:  Cancer Cell Int       Date:  2022-07-29       Impact factor: 6.429

7.  Ruscogenin Protects Against Deoxynivalenol-Induced Hepatic Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis Through the Nrf2 Signaling Pathway: An In vitro Study.

Authors:  Hany Elsawy; Peramaiyan Rajendran; Azza Mahmoud Sedky; Manal Alfwuaires
Journal:  Saudi J Med Med Sci       Date:  2022-08-22

Review 8.  Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia.

Authors:  Tuo Yang; Feng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

9.  ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma.

Authors:  Li Chen; Xiao-Han Jin; Jie Luo; Jin-Ling Duan; Mu-Yan Cai; Jie-Wei Chen; Zi-Hao Feng; Austin Meng Guo; Feng-Wei Wang; Dan Xie
Journal:  Oncogene       Date:  2021-08-06       Impact factor: 9.867

10.  The protective effects of memantine against inflammation and impairment of endothelial tube formation induced by oxygen-glucose deprivation/reperfusion.

Authors:  Xiaoxin Lv; Qiang Li; Shuai Mao; Limin Qin; Peikang Dong
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.